Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
20.75
+0.40 (1.97%)
At close: Jul 14, 2025

Shukra Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Shukra Pharmaceuticals had annual revenue of 367.94M INR, down -51.88%. Shukra Pharmaceuticals had revenue of 147.35M in the quarter ending March 31, 2025, with 29.96% growth.

Revenue
367.94M
Revenue Growth
-51.88%
P/S Ratio
24.69
Revenue / Employee
2.02M
Employees
182
Market Cap
9.09B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Mar 31, 2025 367.94M -396.72M -51.88%
Mar 31, 2024 764.66M 169.73M 28.53%
Mar 31, 2023 594.93M 390.07M 190.41%
Mar 31, 2022 204.86M 92.90M 82.97%
Mar 31, 2021 111.96M -6.50M -5.49%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,646.93B
HDFC Bank 2,728.47B
Tata Consultancy Services 2,561.48B
Bharti Airtel 1,729.85B
ICICI Bank 2,006.54B
State Bank of India 3,429.39B
Infosys 1,647.16B
Hindustan Unilever 631.21B
Revenue Rankings